Skip to content

Enpro NPO Investment Proceeds

Investment Proceeds at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$259.2M-13.0%
Sunoco logo
SunocoSUN
$20M-39.4%
The Trade Desk logo
The Trade DeskTTD
$238.3M+44.3%
MACOM Technology Solutions logo
MACOM Technology SolutionsMTSI
$104.65M-9.1%
Dynatrace logo
DynatraceDT
$39.85M+7.7%
ResMed logo
ResMedRMD
$2.5M

Other financials

Income statement

See full
Revenue$303.0M+10.9%
Gross profit$130.0M+10.0%
Operating income$43.5M+4.1%
Net income$27.4M+11.8%
EPS (diluted)$1.29+12.2%

Balance sheet

See full
Cash & equivalents$79.2M-67.0%
Total debt$617.8M-4.5%
Total equity$1.6B+6.9%
Total assets$2.6B+5.1%

Cash flow

See full
Operating cash flow$39.6M+88.6%
CapEx$12.2M+52.5%
Free cash flow$27.4M+111%

Valuation

See full
Market cap$8.02B+55.5%
Enterprise value$8.56B+53.1%
P/E80.3×
P/S6.8×+2.0×

Profitability

See full
Gross margin42.6%-0.4pp
Operating margin13.9%-0.7pp
Net margin7.8%
FCF margin14.8%+0.8pp

Returns & leverage

See full
Return on equity5.8%
Debt / equity0.4×0.0×
Current ratio2.2×-0.7×

Where this comes from

Reported directly by Enpro in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfShortTermInvestments.

The official record: Enpro’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enpro's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enpro's investment proceeds?
Enpro (NPO) reported investment proceeds of $3.4M in Q1 2026.
What does investment proceeds mean?
Cash received from sales, maturities, and redemptions of investment securities across all categories.